Elecsys Testosterone II
Radioimmunoassay, Testosterones And Dihydrotestosterone. 510(k) K211685, from Roche Diagnostics (Indianapolis, IN). Product code CDZ, class 1.
As of Nov 20, 2026, K211685 is an FDA 510(k) held by Roche Diagnostics, substantially equivalent on May 6, 2022 after 338 days, with no recalls tied to it in FDA's recall database.
- Review time: 338 days
- Recalls: 0
- Cited as a predicate by: 1 device
Immunoassay for the in vitro quantitative determination of testosterone in human serum and plasma. The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 601 immunoassay analyzer.
- Elecsys Testosterone Ii ImmunoassayK093421 · Roche Diagnostics Corp. · Apr 23, 2010
- IDS-iSYS Total TestosteroneK252728 · Immunodiagnostic Systems Limited · Apr 15, 2026
- IDS-iSYS Total TestosteroneK252728 · Immunodiagnostic Systems Limited · Apr 15, 2026
- IDS-iSYS Free TestosteroneK240865 · Immunodiagnostic Systems Limited · Oct 23, 2024
- Access SHBGK233480 · Beckman Coulter, Inc. · Feb 8, 2024
- Access TestosteroneK223405 · Beckman Coulter, Inc. · Jan 13, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 2, 2021
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1680
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files